Whole genome sequencing for rapid characterization of rabies virus using nanopore technology

Bautista, C., Jaswant, G., French, H., Campbell, K., Durrant, R. , Gifford, R. , Kia, G. S.N., Ogoti, B., Hampson, K. and Brunker, K. (2023) Whole genome sequencing for rapid characterization of rabies virus using nanopore technology. Journal of Visualized Experiments(191), e65414. (doi: 10.3791/65414) (PMID:37677046)

[img] Text
299391.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

942kB
[img] Text
299391.pdf - Accepted Version
Available under License Creative Commons Attribution.

524kB

Abstract

Genomic data can be used to track the transmission and geographic spread of infectious diseases. However, the sequencing capacity required for genomic surveillance remains limited in many low- and middle-income countries (LMICs), where dog-mediated rabies and/or rabies transmitted by wildlife such as vampire bats pose major public health and economic concerns. We present here a rapid and affordable sample-to-sequence-to-interpretation workflow using nanopore technology. Protocols for sample collection and the diagnosis of rabies are briefly described, followed by details of the optimized whole genome sequencing workflow, including primer design and optimization for multiplex polymerase chain reaction (PCR), a modified, low-cost sequencing library preparation, sequencing with live and offline base calling, genetic lineage designation, and phylogenetic analysis. Implementation of the workflow is demonstrated, and critical steps are highlighted for local deployment, such as pipeline validation, primer optimization, inclusion of negative controls, and the use of publicly available data and genomic tools (GLUE, MADDOG) for classification and placement within regional and global phylogenies. The turnaround time for the workflow is 2-3 days, and the cost ranges from $25 per sample for a 96 sample run to $80 per sample for a 12 sample run. We conclude that setting up rabies virus genomic surveillance in LMICs is feasible and can support progress toward the global goal of zero dog-mediated human rabies deaths by 2030, as well as enhanced monitoring of wildlife rabies spread. Moreover, the platform can be adapted for other pathogens, helping to build a versatile genomic capacity that contributes to epidemic and pandemic preparedness.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Gifford, Dr Robert and Kia, Grace Sabo Nok and French, Hollie and jaswant, gurdeep and Bautista, Criselda and Brunker, Dr Kirstyn and Durrant, Rowan and Campbell, Kathryn and Hampson, Professor Katie
Authors: Bautista, C., Jaswant, G., French, H., Campbell, K., Durrant, R., Gifford, R., Kia, G. S.N., Ogoti, B., Hampson, K., and Brunker, K.
College/School:College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine
College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Journal of Visualized Experiments
Publisher:JoVE
ISSN:1940-087X
ISSN (Online):1940-087X
Copyright Holders:Copyright © 2023 JoVE
First Published:First published in Journal of Visualized Experiments 191: e65414
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
301620The Science of Rabies EliminationKatie HampsonWellcome Trust (WELLCOTR)207569/Z/17/ZInstitute of Biodiversity, Animal Health and Comparative Medicine
302671SPEEDIERKatie HampsonMedical Research Council (MRC)MR/R025649/1Institute of Biodiversity, Animal Health and Comparative Medicine
312279Implementing genomic surveillance to support SARS-CoV-2 control and mitigation strategies in the PhilippinesKirstyn BrunkerMedical Research Council (MRC)MR/V035444/1Institute of Biodiversity, Animal Health and Comparative Medicine
173707Institutional Strategic Support Fund (2016)Anna DominiczakWellcome Trust (WELLCOTR)204820/Z/16/ZInstitute of Cardiovascular & Medical Sciences
312561EPSRC DTP 2020/21Christopher PearceEngineering and Physical Sciences Research Council (EPSRC)EP/T517896/1Research and Innovation Services
309785Integrative Infection Biology - Mechanisms and Control of DiseaseMatthias MartiWellcome Trust (WELLCOTR)218518/Z/19/ZIII - Parasitology